Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 9/20 | 0.68 |
| ▸ | NPC1 | O15118 | 8/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 8/20 | 0.68 |
| ▸ | LMNA | P02545 | 3/20 | 0.68 |
| ▸ | MAPT | P10636 | 3/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.54 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24921222 | 0.90 | MAPT (0.62) | RAB9ANPC1SMN1; SMN2LMNAMAPT | |
| SCHEMBL24921217 | 0.86 | MAPT (0.61) | RAB9ANPC1SMN1; SMN2LMNAMAPT | |
| SCHEMBL15703736 | 0.84 | RAB9A (0.56) | RAB9ANPC1SMN1; SMN2LMNAMAPT | |
| SCHEMBL13849692 | 0.84 | NPC1 (0.52) | RAB9ANPC1SMN1; SMN2LMNAMAPT | |
| SCHEMBL21051391 | 0.83 | RAB9A (0.58) | RAB9ANPC1SMN1; SMN2LMNAMAPT | |
| SCHEMBL23054249 | 0.83 | RAB9A (0.54) | RAB9ANPC1SMN1; SMN2LMNAMAPT | |
| SCHEMBL21051399 | 0.83 | RAB9A (0.58) | RAB9ANPC1SMN1; SMN2LMNAMAPT | |
| SCHEMBL22503546 | 0.83 | HPGD (0.59) | RAB9ANPC1SMN1; SMN2LMNAMAPT | |
| SCHEMBL21051390 | 0.83 | RAB9A (0.58) | RAB9ANPC1SMN1; SMN2LMNAMAPT | |
| SCHEMBL1928209 | 0.83 | RAB9A (0.54) | RAB9ANPC1SMN1; SMN2LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11693310-B2 | Blue curable resin composition, blue color filter, and display device including same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-07-04 | — | — | US | disclosed |
| US-11693310-B2 | Blue curable resin composition, blue color filter, and display device including same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-07-04 | — | — | US | disclosed |
| US-20230043562-A1 | COLORED RESIN COMPOSITION | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-02-09 | — | — | US | disclosed |
| US-20200371435-A1 | BLUE CURABLE RESIN COMPOSITION, BLUE COLOR FILTER, AND DISPLAY DEVICE INCLUDING SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2020-11-26 | — | — | US | disclosed |
| US-9051397-B2 | Oxime ester | BASF SE (DE) | 2015-06-09 | — | — | US | disclosed |
| US-9051397-B2 | Oxime ester | BASF SE (DE) | 2015-06-09 | — | — | US | disclosed |
| EP-2625166-B1 | OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS | BASF SE (DE) | 2014-09-24 | — | — | EP | disclosed |
| US-20130188270-A1 | OXIME ESTER | BASF SE (DE) | 2013-07-25 | — | — | US | disclosed |
| US-20130188270-A1 | OXIME ESTER | BASF SE (DE) | 2013-07-25 | — | — | US | disclosed |
| WO-2012045736-A1 | OXIME ESTER DERIVATIVES OF BENZOCARBAZOLE COMPOUNDS AND THEIR USE AS PHOTOINITIATORS IN PHOTOPOLYMERIZABLE COMPOSITIONS | BASF SE (DE) | 2012-04-12 | — | — | WO | disclosed |
| US-20110306607-A1 | HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-12-15 | — | — | US | disclosed |
| EP-1630165-B1 | [1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-2-YLUREA DERIVATIVE AND USE THEREOF | NIPPON KAYAKU KK (JP) | 2010-03-31 | — | — | EP | disclosed |
| US-7598244-B2 | [1,2,4]triazolo[1,5,a]pyrimidin-2-ylurea derivative and use thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-10-06 | — | — | US | disclosed |
| US-7598244-B2 | [1,2,4]triazolo[1,5,a]pyrimidin-2-ylurea derivative and use thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2009-10-06 | — | — | US | disclosed |
| US-20070010515-A1 | [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2007-01-11 | — | — | US | disclosed |
| US-20070010515-A1 | [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2007-01-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070010515-A1 | [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof | HLA-C, TPMT, TAP1 | RAB9A 1475/4885NPC1 1668/4885SMN1; SMN2 3178/4885 |
| US-20130188270-A1 | OXIME ESTER | CBR3, CBR1, COX15 | RAB9A 2189/4885NPC1 4075/4885SMN1; SMN2 4294/4885 |
| US-20110306607-A1 | HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS | KCNJ2, TRPV1, KCNJ1 | RAB9A 1457/4885NPC1 830/4885SMN1; SMN2 1198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.